Depressive Symptom Endorsement among Alzheimer’s Disease, Vascular Dementia and Mild Cognitive Impairment
James R. Hall, Leigh Johnson, April Wiechmann, Robert C. Barber, Sid O’Bryant
Department of Psychiatry, Behavioral Health and Clinical Neuroscience, University of North Texas Health Sciences Center, Fort Worth, USA.
Department of Psychiatry, Behavioral Health and Clinical Neuroscience, University of North Texas Health Sciences Center, Fort Worth, USA,Department of Internal Medicine, University of North Texas Health Science Center, Fort Worth, USA.
Institute of Aging and Alzheimer’s Disease Research, University of North Texas Health Science Center, Fort Worth, USA,Department of Pharmacology and Neuroscience, University of North Texas Health Science Center, Fort Worth, USA.
Institute of Aging and Alzheimer’s Disease Research, University of North Texas Health Science Center, Fort Worth, USA,Department of Psychiatry, Behavioral Health and Clinical Neuroscience, University of North Texas Health Sciences Center, Fort Worth, USA.
DOI: 10.4236/ojmp.2012.13006   PDF    HTML     5,026 Downloads   9,060 Views  

Abstract

Background: The Geriatric Depression Scale (GDS) is widely used to assess depressive symptoms in clinical and research settings. This study utilized a 4 factor solution for the 30-item GDS to explore differences in the presentation of depressive symptoms in various types of cognitive impairment. Method: Retrospective chart review was conducted on 254 consecutive cases of community dwelling elderly newly diagnosed with mild Alzheimer’s Dementia (AD) n = 122, mild Vascular Dementia (VaD) n = 71 or Amnestic Mild Cognitive Impairment (aMCI) n = 32 and Non-Amnestic MCI (nMCI) n = 29. Results: Analysis revealed no significant differences (p < 0.05) between the groups for total GDS score, the Dysphoria subscale or Cognitive Impairment subscale. AD endorsed significantly fewer symptoms than VaD on Apathy, Meaninglessness and Dysphoria. AD did not endorse a significantly different number of items than aMCI on any of the subscales. AD endorsed significantly fewer items than nMCI on Apathy and Meaninglessness. VaD endorsed significantly more items than the aMCI only on the Meaninglessness subscale (p > 05). No statistically significant differences were found between VaD and nMCI or between the MCI groups. Conclusions: Support is provided for the use of GDS subscales in a wide range of cognitively impaired elderly. This study suggests in mild dementia the number and type of depressive symptoms vary significantly between AD and VaD. There are indications that aMCI patients are similar in their symptom endorsement to AD and nMCI are similar to VaD which is consistent with some of the notions regarding likely trajectories of the respective MCI groups.

Share and Cite:

J. Hall, L. Johnson, A. Wiechmann, R. Barber and S. O’Bryant, "Depressive Symptom Endorsement among Alzheimer’s Disease, Vascular Dementia and Mild Cognitive Impairment," Open Journal of Medical Psychology, Vol. 1 No. 3, 2012, pp. 32-37. doi: 10.4236/ojmp.2012.13006.

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1] R. C. Castilla-Puentes and M. E. Habeych, “Subtypes of Depression among Patients with Alzheimer’s Disease and Other Dementias,” Alzheimer’s & Dementia, Vol. 6, No. 1, 2010, pp. 63-69. doi:10.1016/j.jalz.2009.04.1232
[2] C. G. Lyketsos, O. Lopez, B. Jones, A. L. Fitzpatrick, J. Breitner and S. DeKosky, “Prevalence of Neuropsychiatric Symptoms in Dementia and Mild Cognitive Impairment: Results from the Cardiovascular Health Study,” Journal of the American Medical Association, Vol. 288, No. 12, 2002, pp. 1475-1483. doi:10.1001/jama.288.12.1475
[3] E. R. Edwards, A. P. Spira, D. E. Barnes and K. Yaffe, “Neuropsychiatric Symptoms in Mild Cognitive Impairment: Differences by Subtype and Progression to Dementia,” International Journal of Geriatric Psychiatry, Vol. 24, No. 7, 2009, pp. 716-722. doi:10.1002/gps.2187
[4] T. Gabryelewicz, et al., “Prevalence of Major and Minor Depression in Elderly Persons with Mild Cognitive Impairment—MADRS Factor Analysis,” International Journal of Geriatric Psychiatry, Vol. 19, No. 2, 2004, pp. 1168-1172. doi:10.1002/gps.1235
[5] K. Lind, ?. Edman, I. Karlsson, M. Sj?gren and A. Wallin, “Relationship between Depressive Symptomatology and the Subcortical Brain Syndrome in Dementia,” International Journal of Geriatric Psychiatry, Vol. 17, No. 8, 2002, pp. 774-778. doi:10.1002/gps.695
[6] E. H. Rubin, L. L. Veiel, D. A. Kinscherf, J. C. Morris and M. Storandt, “Clinically Significant Depressive Symptoms and Very Mild to Mild Dementia of the Alzheimer Type,” International Journal of Geriatric Psychiatry, Vol. 16, No. 7, 2001, pp. 694-701. doi:10.1002/gps.408
[7] P. Naarding, et al., “Depression in Vascular Dementia,” International Journal of Geriatric Psychiatry, Vol. 18, No. 4, 2003, pp. 325-330. doi:10.1002/gps.831
[8] O. L. Lopez and J. T. Becker, “Treatment of Alzheimer’s Disease,” Neurology Review, Vol. 35, No. 9, 2002, pp. 850-859.
[9] O. L. Lopez, et al., “Risk Factors for Mild Cognitive Impairment in the Cardiovascular Health Study Cognition Study: Part 2,” Archives of Neurology, Vol. 60, No. 10, 2003, pp. 1394-1399. doi:10.1001/archneur.60.10.1394
[10] D. E. Barnes, G. S. Alexopoulos, O. L. Lopez, J. D. Williamson and K. Yaffe, “Depressive Symptoms, Vascular Disease, and Mild Cognitive Impairment,” Archives of General Psychiatry, Vol. 63, No. 3, 2006, pp. 273-280. doi:10.1001/archpsyc.63.3.273
[11] M. Crowe, R. Andel, V. Wadley, S. Cook, F. Unverzagt, M. Marsiske and K. Ball, “Subjective Cognitive Function and Decline among Older Adults with Psychometrically Defined Amnestic MCI,” International Journal of Geriatric Psychiatry, Vol. 21, No. 12, 2006, pp. 1187-1192. doi:10.1002/gps.1639
[12] L. Rozzini, et al., “Neuropsychiatric Symptoms in Amnestic and Nonamnestic Mildcognitive Impairment,” Dementia and Geriatric Cognitive Disorders, Vol. 25, No. 1, 2008, pp. 32-36. doi:10.1159/000111133
[13] J. A. Yesavage, et al., “Development and Validation of a Geriatric Depression Screening Scale: A Preliminary Report,” Journal of Psychiatric Research, Vol. 17, No. 1, 1983, pp. 37-49. doi:10.1016/0022-3956(82)90033-4
[14] A. K?rner, et al., “The Geriatric Depression Scale and the Cornell Scale for Depression in Dementia. A Validity Study,” Nordic Journal of Psychiatry, Vol. 60, No. 5, 2006, pp. 360-364. doi:10.1080/08039480600937066
[15] R. S. Wilson, S. E. Arnold, T. L. Beck, J. L. Bienias and D. A. Bennett, “Change in Depressive Symptoms during the Prodromal Phase of Alzheimer Disease,” Archives of General Psychiatry, Vol. 65, No. 4, 2008, pp. 439-446. doi:10.1001/archpsyc.65.4.439
[16] T. Muller-Thomsen, S. Arlt, U. Mann, R. MaB and S. Ganzer, “Detecting Depression in Alzheimer’s Disease: Evaluation of Four Different Scales,” Archives of Clinical Neuropsychology, Vol. 20, No. 2, 2005, pp. 271-276. doi:10.1016/j.acn.2004.03.010
[17] H. Debruyne, et al., “Is the Geriatric Depression Scale a Reliable Screening Tool for Depressive Symptoms in Elderly Patients with Cognitive Impairment?” International Journal of Geriatric Psychiatry, Vol. 24, 2009, pp. 556-662. doi:10.1002/gps.2154
[18] J. R. Hall and T. E. Davis, “Factor structure of the Geriatric Depression Scale with Cognitively Impaired Older Adults,” The Clinical Gerontologist, Vol. 33, No. 1, 2010, pp. 39-48. doi:10.1080/07317110903362127
[19] S. O’Bryant, J. Hall, K. Cukrowicz, M. Edwards, L. Johnson, D. Lefforge, M. Jenkins and A. Dentino, “The Differential Impact of Depressive Symptom Clusters on Cognition in a Rural Multi-Ethnic Cohort: A Project FRONTIER Study,” International Journal of Geriatric Psychiatry, Vol. 26, No. 2, 2011, pp. 199-205. doi:10.1002/gps.2514
[20] L. A. Johnson, C. Mauer, D. Jahn, M. Song, L. Wyshywaniuk, J. R. Hall, V. Balldin and S. E. O’Bryant, “Cognitive Differences among Depressed and Non-Depressed MCI Participants: A Project Frontier Study,” International Journal of Geriatric Psychiatry, 2012, in Press. doi:10.1002/gps.3835
[21] J. R. Hall, S. E. O’Bryant, L. A. Johnson and R. Barber, “Depressive Symptom Clusters and Neuropsychological Performance in Mild Alzheimer’s and Cognitively Intact Elderly,” Journal of Depression Research and Treatment, Vol. 2011, 2011, Article ID 396958, 6 p.
[22] G. McKhann, D. Drachman, M. Folstein, R. Datzman, D. Price and E. M. Stadlan, “Clinical Diagnosis of Alzheimer’s Disease: Report of the NINCDS-ADRDA Work Group under the Auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease,” Neurology, Vol. 34, No. 7, 1984, pp. 939-944. doi:10.1212/WNL.34.7.939
[23] B. Winblad, et al., “Mild Cognitive Impairment-Beyond Controversies, towards a Consensus: Report of the International Working Group on Mild Cognitive Impairment,” Journal of Internal Medicine, Vol. 256, No. 3, 2004, pp. 240-246. doi:10.1111/j.1365-2796.2004.01380.x
[24] Y. Kashiwa, Y. Kitabayashi, J. Narumoto, K. Nakamura, H. Ueda and K. Fukui, “Anosognosia in Alzheimer’s Disease: Association with Patient Characteristics, Psychiatric Symptoms and Cognitive Deficits,” Psychiatry and Clinical Neurosciences, Vol. 59, No. 6, 2005, pp. 697-704. doi:10.1111/j.1440-1819.2005.01439.x
[25] D. C. Chan, J. D. Kasper, B. S. Black and P. V. Rabins, “Prevalence and Correlates of Behavioral and Psychiatric Symptoms in Community-Dwelling Elders with Dementia or Mild Cognitive Impairment: The Memory and Medical Care Study,” International Journal of Geriatric Psychiatry, Vol. 18, No. 2, 2003, pp. 174-182. doi:10.1002/gps.781
[26] V. Solfrizzi, et al., “Italian Longitudinal Study on Aging Working Group,” Dementia and Geriatric Cognitive Disorders, Vol. 24, No. 1, 2007, pp. 55-64. doi:10.1159/000103632
[27] S. Staekenborg, et al., “Behavioural and Psychological Symptoms in Vascular Dementia; Differences between Small and Large Vessel Disease,” Journal of Neurological Neurosurgical Psychiatry, Vol. 81, No. 5, 2010, pp. 547-51. doi:10.1136/jnnp.2009.187500
[28] M. Chan, W. S. Lim and S. Sahadevan, “Stage-Independent and Stage-Specific Phenotypic Differences between Vascular Dementia and Alzheimer’s Disease,” Dementia and Geriatric Cognitive Disorders, Vol. 26, 2008, pp. 513-521. doi:10.1159/000178755
[29] J. M. Ellison, D. G. Harper, Y. Berlow and L. Zeranski, “Beyond the ‘c’ in MCI: Noncognitive Symptoms in Amnestic and Non-Amnestic Mild Cognitive Impairment,” CNS Spectrums, Vol. 13, No. 1, 2008, pp. 66-72.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.